1. Grabowski, H., Vernon, J. & Di Masi, J. A. Returns on research and development for 1990s new drug introductions. Pharamcogenomics 20, S11–S29 (2002).
2. DiMasi, J. A. The value of improving the productivity of the drug development process: faster times and better decisions. Pharmacoeconomics 20, S1–S10 (2002).
3. Sim, P. & Gill, J. Results of the 2002 Drug Discovery Performance Metrics Survey (CMR International, Epsom, UK, 2003).
4. CHI Strategies to Optimize R&D Performance, June 9–19, Philadelphia, Pennsylvania, USA (2003).
5. Phacilitate, Inc. R&D Leaders Forum. October, Geneva, Switzerland (2003).